Blood Pressure and Development of Cardiovascular Disease in Koreans With Type 2 Diabetes Mellitus

被引:33
|
作者
Kim, Mee Kyoung [1 ]
Han, Kyungdo [2 ]
Koh, Eun Sil [3 ]
Kim, Eun Sook [4 ]
Lee, Min-Kyung [5 ]
Nam, Ga Eun [6 ]
Kwon, Hyuk-Sang [1 ]
机构
[1] Catholic Univ Korea, Coll Med, Yeouido St Marys Hosp, Div Endocrinol & Metab,Dept Internal Med, 10 63 Ro, Seoul 07345, South Korea
[2] Catholic Univ Korea, Coll Med, Dept Med Stat, Seoul, South Korea
[3] Catholic Univ Korea, Coll Med, Div Nephrol, Dept Internal Med,Yeouido St Marys Hosp, Seoul, South Korea
[4] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Internal Med,Div Endocrinol & Metab, Seoul, South Korea
[5] Hanyang Univ, Med Ctr, Myongji Hosp, Div Endocrinol & Metab,Dept Internal Med, Goyang Si, South Korea
[6] Korea Univ, Coll Med, Anam Hosp, Dept Family Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
blood pressure; cardiovascular diseases; diabetes mellitus; hypertension; Korea; PULSE PRESSURE; RISK; HYPERTENSION; GUIDELINES; MANAGEMENT; MORTALITY; OUTCOMES; OBESITY; STROKE; HEALTH;
D O I
10.1161/HYPERTENSIONAHA.118.12160
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The objective of this study was to investigate the optimal blood pressure (BP) target to prevent development of cardiovascular diseases (CVDs) in Korean subjects with type 2 diabetes mellitus. Using the Korean National Health Insurance Service database, 2262725 subjects with type 2 diabetes mellitus who underwent regular health checks between 2009 and 2012 were included. Subjects with previous CVDs were excluded. Participants were grouped by 10-mmHg intervals of observed systolic BP (SBP) by 5-mmHg intervals of diastolic BP. There were 124466 deaths (5.50%), 67235 cases of stroke (2.97%), and 41726 myocardial infarctions (1.84%) during a median follow-up of 6.5 years. Compared with SBP 110 to 119 mmHg, there was no increased risk among subjects with SBP 120 to 129 mmHg, but SBP 130 mmHg was associated with a significant increase in the incidence of CVDs. SBP 130 to 139 mmHg was associated with a significant increase in the incidence of stroke (hazard ratio, 1.15; 95% CI, 1.12-1.18) and myocardial infarctions (hazard ratio, 1.05; 95% CI, 1.02-1.09) compared with SBP 110 to 119 mmHg. Subjects with diastolic BP 80 to 84 mmHg had a higher risk of CVDs than subjects with diastolic BP 75 to 79 mmHg. The overall relationship between BP and CVD risk was positive, with a greater strength observed for younger age groups. The optimal cutoff for Korean patients with type 2 diabetes mellitus associated with lower CVD risk may be 130 mmHg for SBP or 80 mmHg for diastolic BP.
引用
收藏
页码:319 / 326
页数:8
相关论文
共 50 条
  • [41] Weight Change, Blood Pressure, Lipids and Glycemic Control among Patients with Type 2 Diabetes
    Janghorbani, Mohsen
    Amini, Masoud
    Salehi-Marzijarani, Mohammad
    ANNALS OF NUTRITION AND METABOLISM, 2011, 58 (02) : 141 - 149
  • [42] Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus
    Moon, Min Kyong
    Noh, Junghyun
    Rhee, Eun-Jung
    Park, Sang Hyun
    Kim, Hyeon Chang
    Kim, Byung Jin
    Kim, Hae Jin
    Choi, Seonghoon
    Na, Jin Oh
    Hyun, Young Youl
    Kim, Bum Joon
    Han, Kyung-Do
    Jeong, In-Kyung
    DIABETES & METABOLISM JOURNAL, 2023, 47 (01) : 45 - 58
  • [43] AMBULATORY BLOOD-PRESSURE AND RISK OF CARDIOVASCULAR-DISEASE IN TYPE-II DIABETES-MELLITUS
    VERDECCHIA, P
    PORCELLATI, C
    SCHILLACI, G
    BORGIONI, C
    CIUCCI, A
    GATTESCHI, C
    ZAMPI, I
    SANTUCCI, A
    SANTUCCI, C
    REBOLDI, G
    DIABETES NUTRITION & METABOLISM, 1994, 7 (04) : 223 - 231
  • [44] A nationwide assessment of blood pressure control and the associated factors in Chinese type 2 diabetes mellitus patients
    Zhang, Yu-Qing
    Li, Yong
    Dong, Yu-Gang
    Wu, Yan-Hua
    Bian, Rui
    Li, Ji-Hu
    Ji, Li-Nong
    JOURNAL OF CLINICAL HYPERTENSION, 2019, 21 (11) : 1654 - 1663
  • [45] Human serum metabolomic analysis reveals progression for high blood pressure in type 2 diabetes mellitus
    Zhang, Yin
    Zhao, Heru
    Liu, Bin
    Shu, Haiyang
    Zhang, Lulu
    Bao, Mei
    Yi, Wenjun
    Tan, Yong
    Ji, Xinyu
    Zhang, Chi
    Zhao, Ning
    Pang, Guoming
    He, Dan
    Wang, Yuexi
    Li, Li
    Yi, Jianfeng
    Lu, Cheng
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [46] Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication
    Mancia, Giuseppe
    Cannon, Christopher P.
    Tikkanen, Ilkka
    Zeller, Cordula
    Ley, Ludwin
    Woerle, Hans J.
    Broedl, Uli C.
    Johansen, Odd Erik
    HYPERTENSION, 2016, 68 (06) : 1355 - 1364
  • [47] Blood pressure variables and cardiovascular risk in type 2 diabetes in the ADVANCE trial
    Kengne, Andre-Pascal
    Czernichow, Sebastien
    Chalmers, John
    SANG THROMBOSE VAISSEAUX, 2010, 22 (05): : 264 - 270
  • [48] Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes
    van Dieren, Susan
    Kengne, Andre P.
    Chalmers, John
    Beulens, Joline W. J.
    Cooper, Mark E.
    Grobbee, Diederick E.
    Harrap, Stephen
    Mancia, Giuseppe
    Neal, Bruce
    Patel, Anushka
    Poulter, Neil
    van der Schouw, Yvonne T.
    Woodward, Mark
    Zoungas, Sophia
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 98 (01) : 83 - 90
  • [49] A Mobile App for Prevention of Cardiovascular Disease and Type 2 Diabetes Mellitus: Development and Usability Study
    Buss, Vera Helen
    Varnfield, Marlien
    Harris, Mark
    Barr, Margo
    JMIR HUMAN FACTORS, 2022, 9 (02):
  • [50] Renal function and blood pressure in type 1 diabetes mellitus
    Ubetagoyena Arrieta, M.
    Areses Trapote, R.
    Artola Aizalde, E.
    Cancela Muniz, V.
    Arruebarrena Lizarraga, D.
    ANALES DE PEDIATRIA, 2013, 78 (02): : 104 - 108